Irena Ilic, MD,  —

Articles by Irena Ilic

Sunovion Divesting U.S. Market Rights to Asthma and Allergic Rhinitis Therapies to Covis Pharma

Sunovion Pharmaceuticals will divest its U.S. market rights for ciclesonide products for the treatment of asthma and allergic rhinitis to Covis Pharma. With this agreement, Sunovion confirms its focus on chronic obstructive pulmonary disease (COPD), and continued development of treatment options for this condition. Sunovion’s ciclesonide products (a type of…